Investor profile
Woodford Investment Management has backed 21 European tech companies across 26 funding rounds between 2014 and 2018, joining rounds totalling €1.1B. Most active in Healthtech and Software. Data as of 7 Aug 2026.
Also recorded as: Woodford Investment Management Ltd
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Gigaclear | UK | 2 | €172M |
| Atom Bank | UK | 1 | €114M |
| Oxford Nanopore Technologies | UK | 1 | €111M |
| BenevolentAI | UK | 1 | €92M |
| CeQur | Switzerland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Gigaclear | Other | €131M | 2017-05 |
| Atom Bank | Growth/Late | €114M | 2015-11 |
| Oxford Nanopore Technologies | Growth/Late | €111M | 2016-04 |
| BenevolentAI |
| 1 |
| €89M |
| Carrick Therapeutics | Ireland | 1 | €86M |
| Benevolent | UK | 1 | €80M |
| Cell Medica | UK | 1 | €64M |
| Ultrahaptics | UK | 3 | €59M |
| Kymab | UK | 1 | €45M |
| Nexeon | UK | 1 | €42M |
| Reaction Engines | UK | 1 | €30M |
| Drayson Technologies | UK | 2 | €28M |
| Genomics | UK | 1 | €28M |
| SEEDrs | UK | 2 | €19M |
| Eve Mattress | UK | 1 | €17M |
| RateSetter | UK | 1 | €15M |
| Oxsybio | UK | 1 | €11M |
| PurpleBricks | UK | 1 | €10M |
| Metaboards | UK | 1 | €4.0M |
| B-Secur | Ireland | 1 | €3.9M |
| Other |
| €92M |
| 2018-02 |
| CeQur | Series C | €89M | 2015-09 |
| Carrick Therapeutics | Series A | €86M | 2016-10 |
| Benevolent | Growth/Late | €80M | 2015-08 |
| Cell Medica | Series B | €64M | 2014-11 |
| Kymab | Series B | €45M | 2015-05 |
| Nexeon | Growth/Late | €42M | 2016-05 |
